GALNS rs569725936: What Your Genotype Means
The rs569725936 variant is a specific change in the GALNS gene associated with carrier status for Mucopolysaccharidosis type IV-A (MPS IVA). Individuals who carry this variant possess one copy of the altered gene, which is inherited in an autosomal recessive pattern.
What each genotype means
Typical GALNS genotype
This genotype represents the common, non-variant form of the GALNS gene at this specific location. It is not associated with the carrier status for Mucopolysaccharidosis type IV-A described for this variant.
This is the most common genotype observed in the general population.
Mucopolysaccharidosis IV-A carrier
This genotype indicates you carry one copy of the variant associated with Mucopolysaccharidosis type IV-A. As a carrier, you typically do not show symptoms of the condition, but you should discuss the implications for family planning with a genetic counselor or healthcare provider.
The frequency of this specific carrier genotype is not widely recorded in general population databases.
Potential clinical significance
This genotype indicates the presence of two copies of the variant. While some sources note this genotype as common in certain clinical databases, its specific clinical impact remains subject to ongoing research and interpretation. Please consult with a medical professional to understand what this result means for your health.
The frequency of this genotype is not well-defined across global populations.
Understanding the rs569725936 Variant
The variant rs569725936 is a single nucleotide polymorphism (SNP) located within the GALNS gene on chromosome 16. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is cataloged in public databases as being associated with carrier status for Mucopolysaccharidosis type IV-A. When a person is a carrier, it means they have one copy of a gene with a variant and one copy of the typical gene. Because this condition follows an autosomal recessive inheritance pattern, carriers typically do not exhibit the symptoms of the disorder themselves. However, they may pass the variant to their children. Understanding your status for such variants is often part of broader carrier screening programs designed to provide information about reproductive risks.
The Role of the GALNS Gene
The GALNS gene provides the essential instructions for the body to produce an enzyme known as N-acetylgalactosamine-6-sulfatase. This enzyme is located within lysosomes, which are the recycling centers of the cell. Its primary responsibility is to break down complex sugar molecules called glycosaminoglycans (GAGs), specifically keratan sulfate and chondroitin-6-sulfate. These molecules are vital components of cartilage and the cornea of the eye. When the GALNS gene functions correctly, the enzyme efficiently removes sulfate groups from these sugars, allowing them to be recycled. If the gene contains pathogenic mutations that significantly reduce or eliminate enzyme activity, these sugar molecules cannot be broken down properly. This leads to their accumulation within the lysosomes, which is the underlying cause of the skeletal and ocular features observed in Mucopolysaccharidosis type IV-A.
Research and Evidence Strength
The association between variants in the GALNS gene and Mucopolysaccharidosis type IV-A is well-established in clinical literature. MPS IVA is a rare, autosomal recessive lysosomal storage disorder. Research indicates that over 300 different variants in the GALNS gene have been identified globally, ranging from missense and nonsense mutations to deletions and splice site alterations. The evidence strength for rs569725936 as a carrier-associated variant is considered moderate, based on its presence in clinical databases. It is important to note that genetic research is an evolving field; while specific variants are linked to carrier status, the clinical impact of any single variant can depend on the presence of other mutations on the same or the opposite chromosome. Scientific consensus relies on large-scale studies to confirm the pathogenicity of specific variants, and findings are often updated as more data becomes available.
Population Frequency and Distribution
Information regarding the specific population frequency of the rs569725936 variant is currently limited, with no widespread frequency data recorded in major public genomic databases. Genetic variants associated with rare conditions like MPS IVA are often found at very low frequencies in the general population. Because MPS IVA is an autosomal recessive condition, the prevalence of carriers is generally low, though it may vary significantly across different ancestral groups due to founder effects or genetic drift. The absence of recorded frequency data does not imply the variant is absent in certain populations, but rather that it has not been frequently observed or reported in large-scale sequencing projects to date. As more individuals participate in genomic research and clinical testing, our understanding of the distribution and prevalence of such rare variants continues to improve.
Interpreting Your Genetic Information
If you have received information about your status for the rs569725936 variant, it is important to understand what this means in a practical context. Being a carrier for an autosomal recessive condition generally does not affect your own health. However, if both parents are carriers of a pathogenic variant in the same gene, there is a statistical possibility of passing the condition to their children. This information is intended for educational purposes and should not be used for self-diagnosis or medical decision-making. Genetic testing results can be complex, and their interpretation often requires the context of your personal and family medical history. If you have concerns about your carrier status or reproductive risks, the most appropriate step is to consult with a certified genetic counselor or a medical professional who can provide personalized guidance based on your specific clinical situation.
How common is this variant?
There is no specific population frequency data recorded for this variant in major public databases, as it is a rare variant associated with a specific genetic condition.
Frequently asked questions
What is Mucopolysaccharidosis type IV-A?
Mucopolysaccharidosis type IV-A, also known as Morquio A syndrome, is a rare, inherited metabolic disorder. It is caused by a deficiency of the enzyme needed to break down certain sugar molecules, leading to skeletal and ocular abnormalities.
Does being a carrier mean I have the disease?
No, being a carrier for an autosomal recessive condition like MPS IVA typically means you have one altered copy of the gene and one normal copy. Carriers usually do not show symptoms of the disorder.
How is this variant inherited?
This variant is inherited in an autosomal recessive manner. This means that for a child to be affected by the condition, they would typically need to inherit a pathogenic variant from both parents.
Should I be worried if I have this variant?
Finding out you are a carrier is common and does not mean you are ill. However, if you are planning a family, you may want to speak with a genetic counselor to understand your reproductive risks.
Where can I get more information about my results?
You should discuss any genetic test results with your primary care physician or a board-certified genetic counselor. They can help interpret the findings in the context of your overall health and family history.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs569725936?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GALNS
This variant is associated with carrier status for Mucopolysaccharidosis type IV-A (Morquio syndrome type A).
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A.
This variant serves as a carrier marker for Mucopolysaccharidosis type IV-A, a lysosomal storage disorder.
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A (Morquio syndrome).
This variant is a pathogenic mutation linked to carrier status for Mucopolysaccharidosis type IV-A.
This variant is identified as a carrier mutation for Mucopolysaccharidosis type IV-A.
